OXOMEMAZINE SUGAR FREE SANDOZ 150ML
search
  • OXOMEMAZINE SUGAR FREE SANDOZ 150ML

Oxomenazine dry cough sugar-free syrup Sandoz 150 ml


€3.01

This medicine contains a phenothiazine antihistamine. It has antitussive and sedative properties.

It is used in the symptomatic treatment of dry coughs, particularly those that occur at night.

48 hours
Qty
In stock

This medicine is best taken at the onset of coughing, at intervals of at least 4 hours. Evening doses should be preferred because of the risk of drowsiness.

Usual dosage:

    • Adults and children over 40 kg (over 12 years of age): 1 x 10 ml measuring cup, 4 times a day.
    • Children 30 to 40 kg (approx. 10 to 12 years): 1 x 10 ml measuring cup, 3 or 4 times a day.
    • Children 20 to 30 kg (approx. 6 to 10 years): 1 x 10 ml measuring cup, 2 or 3 times a day.
    • Children 12 to 20 kg (approx. 2 to 6 years): 1 x 5 ml measuring cup, 2 or 3 times a day. <

p 5 ml p 5 ml
Oxomemazine 1.65 mg 1.65 mg
Sucrose 3,7 g

This medicine is not suitable for the treatment of wet coughs, which are a normal defense mechanism of the body, allowing the evacuation of mucus from the bronchial tubes.

Coughing is a symptom that may reveal a number of illnesses (allergy, heart, lung or digestive disease, etc.): consult your doctor if it persists for more than a few days.

Precautions should be taken in cases of heart disease, epilepsy, liver failure, renal insufficiency and in the elderly, particularly in cases of chronic constipation, prostate adenoma, dizziness or low blood pressure.

Oxomemazine, like other members of the phenothiazine family, may cause photosensitization reactions; avoid exposure to the sun during treatment.

Avoid alcoholic beverages: increased risk of drowsiness.

This drug may induce drowsiness, sometimes intense in some people. This drowsiness may be increased by alcohol or other sedative drugs. Driving and the use of dangerous machinery are strongly discouraged, especially in the hours following intake.

Contraindications

This drug should not be used in the following cases:

  • history of agranulocytosis,
  • risk of angle-closure glaucoma,
  • risk of urine blockage due to prostate adenoma,
  • children under 2 years of age.

Drug interactions

This medicine must not be combined with medicines containing cabergoline or quinagolide: risk of cancelling out their effects.

Inform your doctor or pharmacist if you are taking any other medication with atropinic or sedative effects (tranquilizers, sleeping pills, certain cough or pain medications containing opiates, antidepressants, neuroleptics, etc.).

Pregnancy

Pregnancy:

The effect of this drug during pregnancy is not well known: only your doctor can assess the possible risk of its use in your case.

If taken at the end of pregnancy, monitoring of the newborn may be necessary.

Breast-feeding:

It is not known whether this drug passes into breast milk: as a precautionary measure, it is not recommended during breast-feeding.

Undesirable effects

Drowsiness.

Atropinic effects: dry mouth, accommodation disorders, urinary blockage, constipation, palpitations.

Orthostatic hypotension, dizziness.

Tremors, poor coordination of movements.

Agitation, confusion of ideas.

Allergic reaction, photosensitization.

Abnormal blood count.

3400922400853

Specific References

chat Comments (0)
No customer reviews for the moment.